185 related articles for article (PubMed ID: 17432718)
1. Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma.
Smilowitz HM; Weissenberger J; Weis J; Brown JD; O'Neill RJ; Laissue JA
J Neurosurg; 2007 Apr; 106(4):652-9. PubMed ID: 17432718
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines.
Pohl U; Wick W; Weissenberger J; Steinbach JP; Dichgans J; Aguzzi A; Weller M
Int J Oncol; 1999 Oct; 15(4):829-34. PubMed ID: 10493969
[TBL] [Abstract][Full Text] [Related]
3. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
4. Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway.
Weissenberger J; Priester M; Bernreuther C; Rakel S; Glatzel M; Seifert V; Kögel D
Clin Cancer Res; 2010 Dec; 16(23):5781-95. PubMed ID: 21138870
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of NMDA 2B at S1303 in human glioma peritumoral tissue: implications for glioma epileptogenesis.
Gao X; Wang H; Cai S; Saadatzadeh MR; Hanenberg H; Pollok KE; Cohen-Gadol AA; Chen J
Neurosurg Focus; 2014 Dec; 37(6):E17. PubMed ID: 25434386
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a green fluorescent protein tracing murine model focused on the functions of host components in necrosis repair and the niche of subcutaneously implanted glioma.
Lu ZH; Lv K; Zhang JS; Dai CG; Liu B; Ma XY; He LM; Jia JY; Chen YM; Dai XL; Wang AD; Dong J; Zhang QB; Lan Q; Huang Q
Oncol Rep; 2014 Feb; 31(2):657-64. PubMed ID: 24284913
[TBL] [Abstract][Full Text] [Related]
7. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
8. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
9. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.
Weissenberger J; Steinbach JP; Malin G; Spada S; Rülicke T; Aguzzi A
Oncogene; 1997 May; 14(17):2005-13. PubMed ID: 9160879
[TBL] [Abstract][Full Text] [Related]
10. [Transplantation and magnetic resonance imaging of transplantable human glioma tissue in the brain of nude mice].
Li RJ; Diao Y; Huang Q; Shen JK; Lan Q
Ai Zheng; 2007 Sep; 26(9):937-41. PubMed ID: 17927848
[TBL] [Abstract][Full Text] [Related]
11. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
[TBL] [Abstract][Full Text] [Related]
12. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
[TBL] [Abstract][Full Text] [Related]
13. DNA content and chromosomal composition of malignant human gliomas.
Bigner SH; Bjerkvig R; Laerum OD
Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
[TBL] [Abstract][Full Text] [Related]
14. [Understanding in treating gliomas: an adequate experimental model for each question].
Javerzat S; Bikfalvi A; Hagedorn M
Bull Cancer; 2005 Jul; 92(7):633-5. PubMed ID: 16123001
[TBL] [Abstract][Full Text] [Related]
15. IL-6 is required for glioma development in a mouse model.
Weissenberger J; Loeffler S; Kappeler A; Kopf M; Lukes A; Afanasieva TA; Aguzzi A; Weis J
Oncogene; 2004 Apr; 23(19):3308-16. PubMed ID: 15064729
[TBL] [Abstract][Full Text] [Related]
16. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
Ashley DM; Kong FM; Bigner DD; Hale LP
Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of new transgenic mouse models in glioma research.
Sonabend AM; Ulasov IV; Lesniak MS
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
[TBL] [Abstract][Full Text] [Related]
19. Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.
de Vries NA; Bruggeman SW; Hulsman D; de Vries HI; Zevenhoven J; Buckle T; Hamans BC; Leenders WP; Beijnen JH; van Lohuizen M; Berns AJ; van Tellingen O
Clin Cancer Res; 2010 Jul; 16(13):3431-41. PubMed ID: 20472681
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
Vince GH; Bendszus M; Schweitzer T; Goldbrunner RH; Hildebrandt S; Tilgner J; Klein R; Solymosi L; Christian Tonn J; Roosen K
Exp Neurol; 2004 Dec; 190(2):478-85. PubMed ID: 15530886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
